Venock Inc.

About:

Medical technology startup company specializing in large bore vascular closure following transcatheter cardiovascular therapies

Website: http://www.venock.com

Top Investors: New Age Ventures

Description:

Venock Inc. is MedTech startup with headquarters in New York City and operations in Munich, Germany. The company is specializing in vascular closure of very large bore access sites (>8 mm) from transcatheter cardiovascular therapies. Currently the company is focusing on large bore VENOUS closure. Both because this is a currently unmet need in the industry with a >$2B market, and because this is a much more straightforward path to commercialization in terms of regulatory clinical studies. However, Venock's fundamental principle of closure is effective on large bore access sites in BOTH veins and arteries. The current method of closing such venous access sites is manual compression, which is time consuming, costly, a drain on hospital resources, and results in considerable amount of patient discomfort. The Venock system will attain full closure in 1 minute.